Evolent Health, Inc. (EVH) skyrockets 1.45% since hitting worst price of $10.35

Evolent Health, Inc. (NYSE:EVH) is now up 1.45% compared to a 12-month low of $10.35. We have seen the price to move -8.3% lower and get settled at $10.5 on 11/14/2017. At recent session, it appeared stuck in a range of $10.3 to $11.65. This company shares are 138.86% off its target price of $25.08 and the current market capitalization stands at $851.55M. The recent change has given its price a -35.43% deficit over SMA 50 and -61.82% deficit over its 52-week high. The stock witnessed -34.78% declines, -39.13% declines and -54.55% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found EVH’s volatility during a week at 9.22% and during a month it has been found around 8.28%.

Evolent Health, Inc. (EVH) Top Holders

Institutional investors currently hold around $795 million or 91.1% in EVH stock. Look at its top three institutional owners. Fmr Llc owns $96.47 million in Evolent Health, Inc., which represents roughly 11.33% of the company’s market cap and approximately 12.13% of the institutional ownership. Similar statistics are true for the second largest owner, Jpmorgan Chase & Co, which owns 7,465,019 shares of the stock are valued at $85.47 million. The third largest holder is Vanguard Group Inc, which currently holds $43.17 million worth of this stock and that ownership represents nearly 5.07% of its market capitalization.

Evolent Health, Inc. 13F Filings

At the end of 09/30/2017 reporting period, 108 institutional holders increased their position in Evolent Health, Inc. (NYSE:EVH) by some 20,978,552 shares, 61 decreased positions by 7,027,693 and 23 held positions by 41,397,776. That puts total institutional holdings at 69,404,021 shares, according to SEC filings. The stock grabbed 40 new institutional investments totaling 7,698,405 shares while 20 institutional investors sold out their entire positions totaling 1,331,971 shares.

Evolent Health, Inc. (NYSE:EVH) Insider Trades

Multiple company employees have indulged in significant insider trading. Evolent Health, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that CEO Williams Frank J has sold 16,300 shares of Evolent Health, Inc. (EVH) in trading session dated Aug. 03, 2017. These shares are worth $386,799 and were traded at $23.73 each. The SEC filing shows that Wigginton Steve performed a sale of 6,000 shares. The CEO, Valence Health disposed these shares by way of transaction on Aug. 01, 2017. The company’s shares were given away at $24.64 per share worth to an income of some $147,840 on account of Wigginton Steve.

COO, Peterson Thomas Iii, sold 40,540 common shares of Evolent Health, Inc. (EVH) in the open market. In a transaction dated Jul. 24, 2017, the shares were put up for sale at an average price of $26, raking in a sum of $1,054,040. After this sale, 112,778 common shares of EVH are directly owned by the insider, with total stake valued at $1,184,169.

In the transaction dated Jul. 10, 2017, the great number of shares disposed came courtesy the CFO; Mcgrane Nicholas disposed a total of 1,667 shares at an average price of $25.42, amounting to approximately $42,375. The insider now directly owns 31,589 shares worth $331,685.

Evolent Health, Inc. (EVH) Analyst Guide

Several analysts have released their opinion on Evolent Health, Inc. (NYSE:EVH), with 11 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.

Previous articleHow Anthera Pharmaceuticals, Inc. (ANTH) Is Trading Compared to Moving Averages?
Next articleSince its 52-week low, Rex Energy Corporation (REXX) has marched up 44.12%